PTX Media related, page-700

What's really great about OmniCAR is that we offer the universal fix for more than just the one issue of Cytokine Release Syndrome that besets immunotherapy. This is why the FDA sees the emergence of a universal platform (or a few of them) as an absolute necessity. The industry is screaming out for a decentralised and standardised cell manufacturing system that is the unversal fix for all the
challenges. PTX, in collaboration with TFS, are going to (fingers crossed) bring this solution to the industry.

Once a universal fix for all the challenges that immunotherapy faces is made available (presented on a platter), why would any biotech co. or cancer centre bother trying to overcome them? They'll never need to refer to the cookbook again... and instead, enjoy the fruits of their labour and be the Masterchefs of their own CarT recipes - dishing them out to clinicians and patients around the world! Biotechs will be able to purchase TFS instrumentation that incorporates OmniCAR technology and take solace in the fact that the hard R&D work of solving immunotherapy's stumbling blocks have been removed for them, and they can get back to cooking up storms in their own CarT kitchens. Biotechs and cancer centres can get back to discovering the next CarT therapy in combating cancer (and not be in such a constant chaotic battle).... and ultimately win the war against cancer.

Sheesh, in the meantime, Shell can win back her freedom (maybe with a bit of luck)!!!